Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | ALKS | ADMA | ||
| Company | Eidos Therapeutics Inc | Alkermes Plc | Adma Biologics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 29.54 | 19.87 | ||
| High | 128.49 | 31.24 | 20.00 | ||
| Low | 116.83 | 29.38 | 19.60 | ||
| Last | 122.21 | 31.06 | 19.95 | ||
| Change | -6.23 | +1.58 | +0.03 | ||
| % Change | -4.85% | +5.36% | +0.15% | ||
| Volume | 335,500 | 1,818,800 | 1,784,000 | ||
| 20-Day Average Volume | 113,985 | 1,576,390 | 3,503,795 | ||
| Previous Close | 128.44 | 29.48 | 19.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 28.92 | 20.79 | ||
| 20-Day Raw Stochastic | 36.63% | 95.64% | 29.58% | ||
| 20-Day Relative Strength | 56.42% | 63.54% | 51.93% | ||
| Weighted Alpha | +136.62 | +25.34 | +275.69 | ||
| Today's Opinion | 88% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +6.19% since 11/26/24 | -8.57% since 11/26/24 | ||
| Low | 116.83 on 01/25/21 | 28.63 on 11/27/24 | 18.40 on 12/02/24 | ||
| High | 131.08 on 01/20/21 | 31.24 on 12/04/24 | 22.19 on 11/27/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +16.81% since 11/04/24 | +4.40% since 11/04/24 | ||
| Low | 116.24 on 01/05/21 | 27.11 on 11/19/24 | 18.40 on 12/02/24 | ||
| High | 132.54 on 01/04/21 | 31.24 on 12/04/24 | 23.64 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +9.91% since 09/04/24 | +18.26% since 09/04/24 | ||
| Low | 69.38 on 10/30/20 | 25.65 on 09/10/24 | 15.33 on 10/21/24 | ||
| High | 132.54 on 01/04/21 | 31.24 on 12/04/24 | 23.64 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +31.33% since 06/04/24 | +97.72% since 06/04/24 | ||
| Low | 38.44 on 07/31/20 | 22.90 on 07/10/24 | 10.06 on 06/05/24 | ||
| High | 132.54 on 01/04/21 | 31.24 on 12/04/24 | 23.64 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,769,952 | 4,708,889 | ||
| Shares Outstanding, K | 38,873 | 161,803 | 236,390 | ||
| Annual Sales | 26,690,000 | 1,663,410,000 | 258,220,000 | ||
| Annual Net Income | -37,840,000 | 355,760,000 | -28,240,000 | ||
| Last Quarter Sales | 130,000 | 378,140,000 | 119,840,000 | ||
| Last Quarter Net Income | -30,180,000 | 92,380,000 | 35,910,000 | ||
| 60-Month Beta | -0.16 | 0.49 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.73 on 10/24/24 | 0.15 on 11/07/24 | ||
| Latest Earnings Date | 02/24/21 | 10/24/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.96 | 49.22 | ||